{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:48:29Z","timestamp":1761180509308,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ecl.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T03:47:11Z","timestamp":1753415231000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone Health in Acromegaly"],"prefix":"10.1016","volume":"54","author":[{"given":"Maria Francesca","family":"Birtolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Cristofolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea G.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41574-022-00649-8","article-title":"Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis","volume":"18","author":"Mazziotti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","article-title":"Fracture risk is decreased in acromegaly--a potential beneficial effect of growth hormone","volume":"15","author":"Vestergaard","year":"2004","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/jc.2012-4073","article-title":"Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography","volume":"98","author":"Madeira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3803\/EnM.2023.1782","article-title":"Increased risk of hip fracture in patients with acromegaly: a nationwide cohort study in Korea","volume":"38","author":"Kim","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.008_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00198-023-06800-z","article-title":"Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study","volume":"34","author":"Kwon","year":"2023","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11102-024-01447-3","article-title":"Skeletal fragility in pituitary disease: how can we predict fracture risk?","volume":"27","author":"Bioletto","year":"2024","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.ecl.2025.06.008_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40618-023-02056-w","article-title":"Bone quality in endocrine diseases: determinants and clinical relevance","volume":"46","author":"Cianferotti","year":"2023","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib9","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-19-0184","article-title":"Management of endocrine disease: bone disorders associated with acromegaly: mechanisms and treatment","volume":"181","author":"Mazziotti","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2025.06.008_bib10","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/EJE-20-0415","article-title":"Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study","volume":"183","author":"Pelsma","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.008_bib12","doi-asserted-by":"crossref","first-page":"bvad121","DOI":"10.1210\/jendso\/bvad121","article-title":"Persistent deficits in bone quality in treated acromegaly: evidence from assessments of microstructure","volume":"7","author":"Kuker","year":"2023","journal-title":"J Endocr Soc"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib13","doi-asserted-by":"crossref","first-page":"bvae079","DOI":"10.1210\/jendso\/bvae079","article-title":"Long-term pegvisomant therapy of acromegaly: effects on bone density, turnover and microstructure using HRpQCT","volume":"8","author":"Kuker","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11102-024-01398-9","article-title":"Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience","volume":"27","author":"Chiloiro","year":"2024","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-024-01464-2","article-title":"Growth hormone and bone: a basic perspective","volume":"27","author":"Bolamperti","year":"2024","journal-title":"Pituitary"},{"issue":"22","key":"10.1016\/j.ecl.2025.06.008_bib16","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.210394297","article-title":"Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin","volume":"97","author":"Playford","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1210\/endo.136.4.7895645","article-title":"Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures","volume":"136","author":"Canalis","year":"1995","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/eje.1.01874","article-title":"GH\/IGF-I and bone resorption in vivo and in vitro","volume":"152","author":"Ueland","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-17-0772","article-title":"Effects of active acromegaly on bone mRNA and microRNA expression patterns","volume":"178","author":"Belaya","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz254","article-title":"Increased serum sclerostin levels in patients with active acromegaly","volume":"105","author":"Pekkolay","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.008_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2025.06.008_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7326\/0003-4819-111-7-567","article-title":"Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism","volume":"111","author":"Diamond","year":"1989","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.008_bib23","first-page":"621","article-title":"acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender","volume":"28","author":"Zgliczynski","year":"2007","journal-title":"Neuroendocrinol Lett"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2362.2002.00944.x","article-title":"Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly","volume":"32","author":"Ueland","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.008_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-17-0468","article-title":"Bone microarchitecture and estimated bone strength in men with active acromegaly","volume":"177","author":"Silva","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.008_bib26","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","article-title":"Impaired bone microarchitecture in premenopausal women with acromegaly: the possible role of Wnt signaling","volume":"106","author":"Silva","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","article-title":"Bone histomorphometry in acromegaly patients with fragility vertebral fractures","volume":"21","author":"Dalle Carbonare","year":"2018","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-016-1078-3","article-title":"High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures","volume":"54","author":"Maffezzoni","year":"2016","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-16-0808","article-title":"Bone material strength index as measured by impact microindentation is altered in patients with acromegaly","volume":"176","author":"Malgo","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.008_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10787","article-title":"Endocortical trabecularization in acromegaly: the cause for the paradoxically increased vertebral fracture risk?","volume":"7","author":"Heck","year":"2023","journal-title":"JBMR Plus"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00198-018-4405-0","article-title":"Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry","volume":"29","author":"Leslie","year":"2018","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-18-0881","article-title":"Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study","volume":"180","author":"Kuzma","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2025.06.008_bib33","doi-asserted-by":"crossref","first-page":"bvab090","DOI":"10.1210\/jendso\/bvab090","article-title":"Spine bone texture assessed by trabecular bone score in active and controlled acromegaly: a prospective study","volume":"5","author":"Sala","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11657-021-00986-7","article-title":"Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study","volume":"16","author":"Sorohan","year":"2021","journal-title":"Arch Osteoporos"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000528199","article-title":"Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and meta-analysis","volume":"113","author":"Bioletto","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"1 Suppl 1","key":"10.1016\/j.ecl.2025.06.008_bib36","first-page":"S9","article-title":"HSA: beyond BMD with DXA","volume":"41","author":"Bonnick","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2025.06.008_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bonr.2015.02.003","article-title":"Study of DXA-derived lateral-medial cortical bone thickness in assessing hip fracture risk","volume":"2","author":"Long","year":"2015","journal-title":"Bone Rep"},{"issue":"12","key":"10.1016\/j.ecl.2025.06.008_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10240","article-title":"Hip structure analyses in acromegaly: decrease of cortical bone thickness after treatment: a longitudinal cohort study","volume":"3","author":"Godang","year":"2019","journal-title":"JBMR Plus"},{"issue":"12","key":"10.1016\/j.ecl.2025.06.008_bib39","first-page":"e5088","article-title":"Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density","volume":"106","author":"Kuzma","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.06.008_bib40","article-title":"Beyond bone mineral density: a new dual X-Ray absorptiometry index of bone strength to predict fragility fractures, the bone strain index","volume":"7","author":"Ulivieri","year":"2020","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s12020-024-03863-8","article-title":"DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures and trabecular bone score in acromegaly","volume":"85","author":"Jaafar","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11657-019-0577-2","article-title":"Automated quantitative morphometry of vertebral heights on spinal radiographs: comparison of a clinical workflow tool with standard 6-point morphometry","volume":"14","author":"Engelke","year":"2019","journal-title":"Arch Osteoporos"},{"issue":"8","key":"10.1016\/j.ecl.2025.06.008_bib43","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2025.06.008_bib44","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12020-021-02711-3","article-title":"Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant","volume":"73","author":"Chiloiro","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12020-011-9486-x","article-title":"Influence of diabetes mellitus on vertebral fractures in men with acromegaly","volume":"40","author":"Mazziotti","year":"2011","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","article-title":"New understanding and treatments for osteoporosis","volume":"41","author":"Mazziotti","year":"2012","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12020-017-1391-5","article-title":"Prevalence of morphometric vertebral fractures in \u201cdifficult\u201d patients with acromegaly with different biochemical outcomes after multimodal treatment","volume":"59","author":"Chiloiro","year":"2018","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib49","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jbspin.2020.04.020","article-title":"Acromegaly is associated with vertebral deformations but not vertebral fractures: results of a cross-sectional monocentric study","volume":"87","author":"Plard","year":"2020","journal-title":"Jt Bone Spine"},{"issue":"8","key":"10.1016\/j.ecl.2025.06.008_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1159\/000511811","article-title":"Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with EOS 2D\/3D technology","volume":"111","author":"Cellini","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.ecl.2025.06.008_bib51","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1210\/jc.2016-3693","article-title":"Calcium and bone turnover markers in acromegaly: a prospective, controlled study","volume":"102","author":"Constantin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.008_bib52","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40618-020-01269-7","article-title":"Biochemical bone turnover markers in hormonal disorders in adults: a narrative review","volume":"43","author":"Szulc","year":"2020","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.008_bib53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40618-022-01740-7","article-title":"Direct effects of octreotide on osteoblast cell proliferation and function","volume":"45","author":"Vitali","year":"2022","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib54","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s40618-023-02281-3","article-title":"The direct impact of pegvisomant on osteoblast functions and bone development","volume":"47","author":"Vitali","year":"2024","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mayocp.2021.11.007","article-title":"Diagnosis and treatment of acromegaly: an update","volume":"97","author":"Ershadinia","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101790","article-title":"Growth hormone replacement in adults with cured acromegaly: efficacy and safety","volume":"37","author":"Tritos","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11102-007-0062-6","article-title":"The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly","volume":"11","author":"De Marinis","year":"2008","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.008_bib59","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","article-title":"Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant","volume":"93","author":"Neggers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-009-0169-z","article-title":"Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review","volume":"13","author":"Mazziotti","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.008_bib62","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz054","article-title":"Effects of pegvisomant and pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs","volume":"105","author":"Chiloiro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.008_bib63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11102-024-01468-y","article-title":"Novel approach to bone comorbidity in resistant acromegaly","volume":"27","author":"Frara","year":"2024","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.008_bib64","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa363","article-title":"Treatment of acromegalic osteopathy in real-life clinical practice: the BAAC (Bone Active Drugs in Acromegaly) study","volume":"105","author":"Mazziotti","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.008_bib65","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1210\/clinem\/dgad493","article-title":"Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly","volume":"109","author":"Chiloiro","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.008_bib66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40618-023-02174-5","article-title":"Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors","volume":"47","author":"Antonini","year":"2024","journal-title":"J Endocrinol Investig"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985292500074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985292500074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:33:12Z","timestamp":1761147192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985292500074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S088985292500074X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.06.008","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Health in Acromegaly","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}